1,809
Views
14
CrossRef citations to date
0
Altmetric
Research Paper

Metuzumab enhanced chemosensitivity and apoptosis in non-small cell lung carcinoma

, , , , , , , , , , , , & show all
Pages 51-62 | Received 02 Jun 2016, Accepted 18 Dec 2016, Published online: 05 Jan 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Miao Wang, Shuai Zhang, Qian Sun, Xiangmin Yang, Yu Wang, Runze Shang, Yumeng Zhu, Hui Yao & Yu Li. (2019) Dual effects of an anti-CD147 antibody for Esophageal cancer therapy. Cancer Biology & Therapy 20:12, pages 1443-1452.
Read now

Articles from other publishers (13)

Alphonce M. K. Nyalali, Angela U. Leonard, Yongxiang Xu, Huayu Li, Junlin Zhou, Xinrui Zhang, Tibera K. Rugambwa, Xiaohan Shi & Feng Li. (2023) CD147: an integral and potential molecule to abrogate hallmarks of cancer. Frontiers in Oncology 13.
Crossref
Sergei S. Naumov, Denis E. Kulbakin, Nadezhda V. Krakhmal & Sergey V. Vtorushin. (2023) Molecular and biological factors in the prognosis of head and neck squamous cell cancer. Molecular Biology Reports.
Crossref
Wenwen Zhang, Meihua Liu, Yurou Ji, Dake Yu, Chuanrui Ma, Jianguo Zhao & Pengpeng Qu. (2023) Tanshinone IIA inhibits endometrial carcinoma growth through the MAPK/ERK/TRIB3 pathway. Archives of Biochemistry and Biophysics 743, pages 109655.
Crossref
Nutjeera Intasai, Kuntalee Rangnoi, Montarop Yamabhai, Thanathat Pamonsupornwichit, Weeraya Thongkum, Umpa Yasamut, Koollawat Chupradit, Nuchjira Takheaw, Piyarat Nimmanpipug & Chatchai Tayapiwatana. (2022) Immunoreactivity of humanized single-chain variable fragment against its functional epitope on domain 1 of CD147. Scientific Reports 12:1.
Crossref
Michal A. Rahat. (2022) Mini-Review: Can the Metastatic Cascade Be Inhibited by Targeting CD147/EMMPRIN to Prevent Tumor Recurrence?. Frontiers in Immunology 13.
Crossref
Mónica Gabriela Sánchez-Salazar, Mario Moisés Álvarez & G. Trujillo-de Santiago. (2021) Advances in 3D bioprinting for the biofabrication of tumor models. Bioprinting 21, pages e00120.
Crossref
Yinghui Zhou, Ming Zheng, Zhenyu Liu, Haijiao Yang, Ping Zhu, Jian-Li Jiang, Juan Tang & Zhi-Nan Chen. (2020) CD147 promotes DNA damage response and gemcitabine resistance via targeting ATM/ATR/p53 and affects prognosis in pancreatic cancer. Biochemical and Biophysical Research Communications 528:1, pages 62-70.
Crossref
Majed Al Fayi, Ahmad Alamri & Prasanna Rajagopalan. (2020) IOX-101 Reverses Drug Resistance Through Suppression of Akt/mTOR/NF-κB Signaling in Cancer Stem Cell-Like, Sphere-Forming NSCLC Cell. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 28:2, pages 177-189.
Crossref
Julieta Afonso, Lúcio L. Santos, Adhemar Longatto-Filho & Fátima Baltazar. (2020) Competitive glucose metabolism as a target to boost bladder cancer immunotherapy. Nature Reviews Urology 17:2, pages 77-106.
Crossref
Yu‐Le Yong, Ren‐Yu Zhang, Ze‐Kun Liu, Ding Wei, Yu‐Kui Shang, Jiao Wu, Zhi‐Yun Zhang, Can Li, Zhi‐Nan Chen & Huijie Bian. (2019) Gamma‐secretase complex‐dependent intramembrane proteolysis of CD147 regulates the Notch1 signaling pathway in hepatocellular carcinoma. The Journal of Pathology 249:2, pages 255-267.
Crossref
Fei Guo, Xueyan Li, Guodong Yao, Guangchun Zeng & Lijuan Yu. (2019) Correlation between 18 F-FDG maximum standardized uptake value with CD147 expression in lung adenocarcinomas: a retrospective study . PeerJ 7, pages e7635.
Crossref
Yang Li, Ting Zhang, Yuan Pang, Ling Li, Zhi-Nan Chen & Wei Sun. (2019) 3D bioprinting of hepatoma cells and application with microfluidics for pharmacodynamic test of Metuzumab. Biofabrication 11:3, pages 034102.
Crossref
Bin Huang, Manping Huang & Qin Li. (2019) Cancer-Associated Fibroblasts Promote Angiogenesis of Hepatocellular Carcinoma by VEGF -Mediated EZH2/VASH1 Pathway . Technology in Cancer Research & Treatment 18, pages 153303381987990.
Crossref